Patients in England with an inherited blood disorder are to become the first in Europe to benefit from a gene therapy costing well over one million pounds a shot. The treatment, called Casgevy, uses ‘molecular scissors’ to disable a faulty gene that causes the debilitating condition beta-thalassaemia. Currently people severely affected by the disease need…

Continue Reading